Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate From China

Ellipses and Innolake will collaborate closely on the development of ILB-3101/EP0028, which is currently in a Phase 1 trial in China sponsored by Innolake. Ellipses will initiate a Phase 1 clinical ...
Slate

What the

Earlier this summer, Choire Sicha, the writer, editor, and co-founder of the Awl, came to an unpleasant realization. His emails, he noticed, had veered into the realm of the ridiculous. “Suddenly, one ...